Percutaneous Septal Ablation for Hypertrophic Cardiomyopathy and Mid-ventricular Obstruction

European Journal of Echocardiography

Volumn 1, Issue 4, 2000, Pages 277-280

  Seggewiss, H ^a   Faber, L ^b  

^a Medizinische Klinik   (Germany)

^b NONE

Author keywords

Hypertrophic cardiomyopathy; mid ventricular obstruction; percutaneous septal ablation.

Indexed keywords

ARTICLE; CASE REPORT; CATHETER ABLATION; FEMALE; HEART OUTFLOW TRACT OBSTRUCTION; HEART VENTRICLE SEPTUM; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MIDDLE AGED;

CARDIOMYOPATHY, HYPERTROPHIC; CATHETER ABLATION; FEMALE; HEART SEPTUM; HUMANS; MIDDLE AGED; VENTRICULAR OUTFLOW OBSTRUCTION;

EID: 0034584528     PISSN: 15252167     EISSN: None     Source Type: Journal    
DOI: 10.1053/euje.2000.0032     Document Type: Article

References (19)

1. Mc Kenna WJ, Coccolo F, Elliot PM. Genes and disease expression in hypertrophic cardiomyopathy. Lancet. 352:1998;1162-1163.
2. Wigle ED, Rakowski H, Kimball BP, Williams WG. Hypertrophic cardiomyopathy: Clinical spectrum and treatment. Circulation. 92:1995;1680-1692.
3. Spirito P, Seidman CE, McKenna WJ, Maron BJ. The management of hypertrophic cardiomyopathy. N Engl J Med. 336:1997;775-785.
4. Schulte HD, Gramsch-Zabel H, Schwartzkopff B. Hypertrophe obstruktive Kardiomyopathie: Chirurgische Behandlung. Schweiz Med Wschr. 125:1995;1940-1949.
5. Heric B, Lytle BW, Miller DP, Rosenkranz ER, Lever HM, Cosgrove DM. Surgical management of hypertrophic obstructive cardiomyopathy: early and late results. J Thorac Cardiovasc Surg. 110:1995;195-208.
6. Sigwart U. Non-surgical myocardial reduction of hypertrophic obstructive cardiomyopathy. Lancet. 346:1995;211-214.
7. Seggewiss H, Gleichmann U, Faber L, Fassbender D, Schmidt HK, Strick S. Percutaneous transluminal septal myocardardial ablation (PTSMA) in hypertrophic obstructive cardiomyopathy: acute results and 3-month follow-up in 25 patients. J Am Coll Cardiol. 31:1998;252-258.
8. Faber L, Seggewiss H, Gleichmann U. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute and 3-months follow-up results with respect to myocardial contrast echocardiography. Circulation. 98:1998;2415-2421.
9. Faber L, Seggewiss H, Fassbender D, Strick S, Bogunovic N, Gleichmann U. Catheter treatment in hypertrophic obstructive cardiomyopathy: identification of the perfusion area of septal branches by myocardial contrast echocardiography (MCE): first experiences. Eur Heart J. 18:1997;368.
10. Gleichmann U, Seggewiss H, Faber L, Fassbender D, Schmidt HK, Strick S. Kathetertherapie der hypertrophen obstruktiven Kardiomyopathie. Dtsch Med Wschr. 21:1996;679-685.
11. Knight C, Kurbaan AS, Seggewiss H. Non-surgical septal reduction for hypertrophic obstructive cardiomyopathy: outcome in the first series of patients. Circulation. 95:1997;2075-2081.
12. Nagueh SF, Lakkis NM, He Z-X. Role of myocardial contrast echocardiography during nonsurgical reduction therapy for hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol. 32:1998;225-229.
13. Maron BJ. Appraisal of dual-chamber pacing therapy in hypertrophic cardiomyopathy: too soon for a rush to judgment? J Am Coll Cardiol. 27:1996;431-432.
14. Nishimura RA, Trusty JM, Hayes DL. Dual-chamber pacing for hypertrophic cardiomyopathy: A randomized, double blind, crossover trial. J Am Coll Cardiol. 29:1997;435-441.
15. Maron BJ, Nishimura RA, McKenna WJ, Rakowski H, Josephson ME, Kieval RS. Assessment of dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy: a randomized double blind, crossover study (M-PATHY). Circulation. 99:1999;2927-2933.
16. Woo A, Wigle ED, Rakowski RC, Siu SC, Rakowski H. Long-term outcome of hypertrophic cardiomyopathy with mid-ventricular obstruction. J Am Coll Cardiol. 31:1998;182A.
17. Hintringer F, Nesser HJ, Niel J, Baumgartner G, Aichinger J. Pacing in distal left ventricular hypertrophic cardiomyopathy. PACE. 21:1998;1828-1830.
18. Faber L, Seggewiss H, Ziemssen P, Gleichmann U. Intraprocedural myocardial contrast echocardiography as a routine procedure in percutaneous transluminal septal myocardial ablation: Detection of threatening myocardial necrosis distant from the septal target area. Cardiovasc Cardiovasc Intervent. 47:1999;462-466.
19. Seggewiss H, Faber L, Gleichmann U. Percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy. Thorac Cardiovasc Surg. 47:1999;94-100.